Showing results (151-160 of 351) with videos related to

Sort By:
Pageof 36
Journal of Medical Virology|January 13, 2017
Ledipasvir plus sofosbuvir as salvage therapy for HCV genotype 1 failures to prior NS5A inhibitors regimensNorio Akuta, Hitomi Sezaki, Fumitaka Suzuki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 9, 2014
Effectiveness and safety of reduced-dose telaprevir-based triple therapy in chronic hepatitis C patientsHitomi Sezaki, Fumitaka Suzuki, Tetsuya Hosaka, et al.
Intervirology|October 6, 2012
Efficacy and anticarcinogenic activity of ribavirin combination therapy for hepatitis C virus-related compensated cirrhosisNorio Akuta, Fumitaka Suzuki, Yuya Seko, et al.
Hepatology (Baltimore, Md.)|September 20, 2012
Effect of type 2 diabetes on risk for malignancies includes hepatocellular carcinoma in chronic hepatitis CYasuji Arase, Mariko Kobayashi, Fumitaka Suzuki, et al.
Journal of Medical Virology|August 30, 2012
Association of IL28B genotype and viral response of hepatitis C virus genotype 2 to interferon plus ribavirin combination therapyNorio Akuta, Fumitaka Suzuki, Yuya Seko, et al.
BMC Gastroenterology|November 20, 2021
PNPLA3 genotype and fibrosis-4 index predict cardiovascular diseases of Japanese patients with histopathologically-confirmed NAFLDNorio Akuta, Yusuke Kawamura, Yasuji Arase, et al.
BMC Gastroenterology|December 14, 2016
Analysis of association between circulating miR-122 and histopathological features of nonalcoholic fatty liver disease in patients free of hepatocellular carcinomaNorio Akuta, Yusuke Kawamura, Fumitaka Suzuki, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 15, 2007
New ablation procedure for a radiofrequency liver tissue coagulation system using an expandable needleMiharu Hirakawa, Kenji Ikeda, Yusuke Kawamura, et al.
Intervirology|October 9, 2008
The efficacy of 24-week interferon monotherapy for type C liver cirrhosis in Japanese patients with genotype 1b and low virus loadYasuji Arase, Fumitaka Suzuki, Hitomi Sezaki, et al.
Intervirology|August 31, 2007
Prediction of response to pegylated interferon and ribavirin in hepatitis C by polymorphisms in the viral core protein and very early dynamics of viremiaNorio Akuta, Fumitaka Suzuki, Yusuke Kawamura, et al.
Pageof 36